FN Clarivate Analytics Web of Science
VR 1.0
PT J
ID PHOTOMULTIPLIER TUBES
ER

PT J
ER

PT J
ID SHORT-TERM-MEMORY; PHONOLOGICAL AWARENESS; DEAF-CHILDREN; HEARING-LOSS;
   SPEECH RECOGNITION; LANGUAGE-SKILLS; READING-ABILITY; SERIAL-RECALL;
   POOR READERS; INTELLIGIBILITY
ER

PT J
ID PPQ LEVEL; KRYPTON
ER

PT J
DE disorders of memory content; electrical brain stimulation; fear memory;
   memory erasure; memory trace; reconsolidation blockade
ID POSTTRAUMATIC-STRESS; STIMULATION; RECONSOLIDATION; DISORDERS; FEAR;
   MODULATION
ER

PT J
ID MYELIN OLIGODENDROCYTE GLYCOPROTEIN; ACUTE DISSEMINATED
   ENCEPHALOMYELITIS; PEDIATRIC MULTIPLE-SCLEROSIS; NEUROMYELITIS-OPTICA;
   SPECTRUM DISORDERS; DISEASES; NMO; AUTOIMMUNITY; MULTICENTER;
   DISTINCTION
ER

PT J
DE atypical demyelination; autoantibodies; myelin oligodendrocyte
   glycoprotein; neuromyelitis optica spectrum disorders; optic neuritis
ID OPTICA SPECTRUM DISORDERS; NEUROMYELITIS-OPTICA; MOG-ANTIBODY;
   DEMYELINATING DISEASES; MULTIPLE-SCLEROSIS; DISSEMINATED
   ENCEPHALOMYELITIS; NMO; MULTICENTER; IGG; NEURITIS
ER

PT J
DE myelin oligodendrocyte glycoprotein; demyelination; autoantibodies;
   inflammation; MOG
ID EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; CENTRAL-NERVOUS-SYSTEM;
   EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; EXTENSIVE TRANSVERSE MYELITIS;
   ANTI-MOG ANTIBODIES; OPTICA SPECTRUM DISORDERS; ENCEPHALITOGENIC
   T-CELLS; TRANSGENIC MOUSE MODEL; MULTIPLE-SCLEROSIS;
   NEUROMYELITIS-OPTICA
ER

PT J
ID RANDOMIZED CONTROLLED-TRIAL; MENTAL-HEALTH-SURVEY; PRIMARY-CARE; PATIENT
   DATA; PSYCHOLOGICAL TREATMENTS; MAJOR DEPRESSION; PSYCHOTHERAPY;
   INTERVENTIONS; PHARMACOTHERAPY; PREDICTORS
ER

PT J
ER

PT J
DE Multiple sclerosis; Iron rim; Phase; 7 T MRI; SWI
ID WHITE-MATTER LESIONS; REMYELINATED-LESIONS; ACTIVATION STATUS; TESLA;
   DEMYELINATION; INJURY; SENSITIVITY; DAMAGE; SWI
ER

PT J
ID FIXED PARTIAL DENTURES; COMPLICATIONS; PROSTHESES
ER

PT J
ID SPECTRUM
ER

PT J
DE Internet-based treatment; Depression; Cognitive behavioral treatment
   (CBT); Blended treatment; Comparative effectiveness research (CER);
   Cost-effectiveness; Randomized controlled trial (RCT); Adults; iCBT;
   eHealth
ID PATIENT HEALTH QUESTIONNAIRE; COGNITIVE-BEHAVIORAL THERAPY;
   COST-EFFECTIVENESS; MAJOR DEPRESSION; METAANALYSIS; DISORDERS; CARE;
   PSYCHOTHERAPY; INTERVENTIONS; EXPECTATIONS
ER

PT J
DE dark matter simulations; dark matter experiments
ID LARGE-SCALE STRUCTURE; LIQUID XENON; SCINTILLATION LIGHT;
   REFRACTIVE-INDEX; DETECTOR; RADIOACTIVITY; BACKGROUNDS; SYSTEM; ARGON;
   RUN
ER

PT J
DE acquisition; digit span; language; language age; short-term auditory
   memory
ER

PT B
DE DRAM Cell transistor; Peripheral transistor; implant and anneal process;
   hardware requirement
ER

PT B
DE Nano memory; electrical pulse; CNT
ER

PT J
DE Internet intervention; Cognitive behaviour therapy; Depression;
   Randomized controlled trial
ID COGNITIVE-BEHAVIORAL THERAPY; INDIVIDUAL PATIENT DATA; SELF-HELP;
   SUBTHRESHOLD DEPRESSION; INITIAL SEVERITY; METAANALYSIS; EFFICACY;
   PSYCHOTHERAPY; INTERVIEW; DISORDER
ER

PT J
ER

PT J
DE Internet interventions; Depression; ICBT; Attitudes; Questionnaire
ID RANDOMIZED CONTROLLED-TRIAL; COGNITIVE-BEHAVIOR THERAPY; DEPRESSION
   SEVERITY; MENTAL-DISORDERS; PRIMARY-CARE; FIT INDEXES; INTERNET;
   PSYCHOTHERAPY; ACCEPTABILITY; VALIDITY
ER

PT J
DE Children; Cochlear implants; Working memory; Short-term memory; Reading;
   Modality
ID NORMAL-HEARING; DEAF-CHILDREN; LANGUAGE; SKILLS; COMPREHENSION
ER

PT J
ID PHASE HYDROTHERMAL METHOD; ATOMIC-FORCE MICROSCOPY; MAGNESIUM-OXIDE;
   OPTICAL-PROPERTIES; SURFACE HYDROXYLATION; NANOPARTICLES IMPACT;
   METAL-OXIDES; KINETICS; STABILITY; MECHANISM
ER

PT J
ID MULTIPLE-SCLEROSIS; DEMYELINATING DISEASES; NEUROMYELITIS-OPTICA;
   PROGNOSTIC-FACTORS; CHILDHOOD; CHILDREN; MOG; DISORDERS; NEURITIS;
   ANTIGEN
ER

PT J
ID REACTIVE OXYGEN; MOUSE MODEL; CELLS; INHIBITION; DISEASE; DEFICIENCY;
   METABOLISM; INDUCTION; REDUCTASE; ONCOGENE
ER

PT J
DE Integrated crop-livestock-forestry systems; Agricultural
   intensification; Land-use change; Innovation diffusion; ABC credit
   program
ID GREENHOUSE-GAS EMISSIONS; TECHNOLOGY ADOPTION; DEFORESTATION;
   AGRICULTURE; PASTURE; AMAZON; LAND
ER

PT J
DE Heating, chromospheric; Heating, coronal; Chromosphere, models;
   Chromosphere, active; Corona, active; Magnetic fields, chromosphere;
   Instrumentation and data management; Spectrum, ultraviolet
ID MG-II-H; FARLEY-BUNEMAN INSTABILITY; DYNAMICS-OBSERVATORY SDO; SOLAR
   CORONA; K-LINES; ACTIVE-REGION; ALFVEN WAVES; SPECTROSCOPIC
   OBSERVATIONS; OSO-8 OBSERVATIONS; PROPAGATING WAVES
ER

PT J
DE Internet-based treatment; anxiety disorders; guided self-help;
   randomized controlled trial
ID COGNITIVE-BEHAVIOR THERAPY; SOCIAL PHOBIA; PANIC DISORDER;
   POSTTRAUMATIC-STRESS; FOLLOW-UP; PSYCHOMETRIC PROPERTIES;
   MENTAL-DISORDERS; DEPRESSION; METAANALYSIS; INVENTORY
ER

PT J
DE Ion implantation; NiTi shape memory alloy; Micro-, nano-indentation
ID MEDICAL APPLICATIONS; NANOINDENTATION; DEFORMATION; BEHAVIOR
ER

PT J
DE Borderline personality disorder; Motive-oriented therapeutic
   relationship; Plan analysis; General psychiatric management; Randomized
   controlled trial; Outcome; Therapeutic alliance
ID DIALECTICAL BEHAVIOR-THERAPY; WORKING ALLIANCE INVENTORY; 2-YEAR
   FOLLOW-UP; PSYCHOMETRIC PROPERTIES; PLAN ANALYSIS; PSYCHOTHERAPY;
   METAANALYSIS; VALIDATION; COMPONENT; PATTERNS
ER

PT J
DE cognitive endophenotypes; dimensional approaches; cognitive processing;
   models for psychopathology; cognitive behavioural therapy;
   effectiveness; children; adolescents; e-mental health
ID RANDOMIZED CONTROLLED-TRIAL; COGNITIVE-BEHAVIORAL THERAPY;
   POSTTRAUMATIC-STRESS-DISORDER; OBSESSIVE-COMPULSIVE DISORDER;
   GENERALIZED ANXIETY DISORDER; INTERNET-BASED TREATMENT;
   ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; AUTOBIOGRAPHICAL MEMORY
   SPECIFICITY; REALITY EXPOSURE THERAPY; PLACEBO-CONTROLLED TRIAL
ER

PT J
DE Ethiopia; adoption and diffusion; smallholder agriculture; conservation;
   soil erosion
ID TECHNOLOGY ADOPTION; NORTHERN THAILAND; AGRICULTURE; DIFFUSION;
   CONSERVATION; CONSTRAINTS; DEPENDENCE; TANZANIA; INCOME; GROWTH
ER

PT J
DE Multiple sclerosis; JC virus; natalizumab; STRATIFY-JCV; anti-JCV
   antibodies; epidemiology; infection risk; international study; antibody
   prevalence; immunosuppressant therapy; brain infection
ID PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; RISK
ER

PT J
ID MULTIPLE-SCLEROSIS; NEUROMYELITIS-OPTICA; MONOCLONAL-ANTIBODY;
   MYELIN/OLIGODENDROCYTE GLYCOPROTEIN; DEMYELINATING DISEASES;
   AUTOANTIBODY RESPONSE; SERUM ANTIBODIES; SELF-ANTIGEN; PROTEIN;
   SPECIFICITY
ER

PT J
DE Subclinical depression; Major depression; Prevention; Treatment; Online
   psychological treatment; Self-help; Guided self-help; Randomized
   controlled trial; Health economic evaluation; Cost-of-illness analysis
ID COMPUTER-ADAPTIVE TEST; ANXIETY DISORDERS; MAJOR DEPRESSION;
   MENTAL-DISORDERS; TREATMENT GAP; RATING-SCALE; SELF-HELP; PSYCHOTHERAPY;
   QUESTIONNAIRE; SEVERITY
ER

PT J
DE acetylcholine; auditory cortex; brain stimulation; neurophysiology;
   nucleus basalis
ID PRIMARY AUDITORY-CORTEX; RECEPTIVE-FIELD PLASTICITY; NUCLEUS BASALIS
   STIMULATION; PRIMARY VISUAL-CORTEX; ASSOCIATIVE MEMORY; CHOLINERGIC
   MODULATION; HARNESSING PLASTICITY; FOREBRAIN STIMULATION;
   REPRESENTATIONAL AREA; CEREBRAL-CORTEX
ER

PT J
ID MYELIN-OLIGODENDROCYTE GLYCOPROTEIN; ACUTE DISSEMINATED
   ENCEPHALOMYELITIS; PEDIATRIC MULTIPLE-SCLEROSIS; NEUROMYELITIS-OPTICA;
   T-CELL; MYELIN/OLIGODENDROCYTE GLYCOPROTEIN; AUTOIMMUNE DEMYELINATION;
   VIRAL ENCEPHALITIS; B-CELLS; ANTIBODIES
ER

PT J
DE Neuromyelitis optica; children; MOG antibodies; optic neuritis; AQP-4
   antibodies
ID DEMYELINATING DISEASES; IGG PREDICTS; DISORDERS; AUTOIMMUNITY; NEURITIS
ER

PT J
DE activity dependent; columnar organization; development; in vivo; newborn
   rat
ID OCULAR DOMINANCE COLUMNS; DEVELOPING SOMATOSENSORY CORTEX; MOUSE
   CEREBRAL-CORTEX; CAT VISUAL-CORTEX; IN-VIVO; SPINDLE BURSTS; CORTICAL
   CIRCUITS; POSTNATAL-DEVELOPMENT; NEURONAL-ACTIVITY; SUBPLATE NEURONS
ER

PT J
ER

PT J
ID INTERLEUKIN-1 RECEPTOR ANTAGONIST; FAMILIAL MEDITERRANEAN FEVER; COLD
   AUTOINFLAMMATORY SYNDROME; AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME;
   MULTISYSTEM INFLAMMATORY DISEASE; JUVENILE IDIOPATHIC ARTHRITIS;
   MUCKLE-WELLS-SYNDROME; ENCODING MEVALONATE KINASE; DORSAL-VENTRAL
   POLARITY; INNATE IMMUNE-RESPONSE
ER

PT J
DE Lithium-sulfur; Binder free; CNT; High sulfur load; Costs calculation
ID CARBON NANOTUBES; BATTERIES; PERFORMANCE
ER

PT S
DE implant; bone; stiffness; NiTi; Nitinol; SMA; SME; shape memory; laser
ID MACHINING CHARACTERISTICS; ALLOYS; NICKEL; FRACTURES; LOCKING; NITINOL;
   DESIGN; BONE
ER

PT J
DE Induction heating; Shape memory alloy (SMA); NiTi; Nitinol; Implant;
   Stiffness
ID ALLOY; NICKEL; NITINOL; BIOCOMPATIBILITY; SCOLIOSIS; POLYMERS; SURFACE
ER

PT J
DE Internet-based; Web-based; Attention bias modification training; Social
   anxiety disorder; Randomized controlled trial
ID DIFFICULTY DISENGAGING ATTENTION; COMORBIDITY SURVEY REPLICATION;
   SELECTIVE ATTENTION; SELF-REPORT; PHOBIA; THREAT; DISORDER; BIASES;
   DEPRESSION; INDIVIDUALS
ER

PT J
DE Social anxiety disorder; Internet-based self-help; structured diagnostic
   interview; randomized controlled trial
ID COMORBIDITY SURVEY REPLICATION; COGNITIVE-BEHAVIORAL THERAPY; PANIC
   DISORDER; PSYCHOLOGICAL TREATMENTS; FOLLOW-UP; PHOBIA; DEPRESSION;
   PROGRAM; METAANALYSIS; STRATEGIES
ER

PT J
ID LONG-TERM RETENTION; EVENT PLAUSIBILITY; CHILDHOOD MEMORIES;
   AUTOBIOGRAPHICAL MEMORY; SUGGESTIBILITY; INFORMATION; BELIEFS;
   PREVALENCE; DETAILS
ER

PT J
DE electrochemistry; heterogeneous catalysis; nanostructures;
   photochemistry; titanium dioxide
ID SENSITIZED SOLAR-CELLS; TIO2 NANOTUBE ARRAYS; THIN-FILM ELECTRODES;
   CHEMICAL-VAPOR-DEPOSITION; ASSISTED PHOTOCATALYTIC DEGRADATION;
   RECHARGEABLE LITHIUM BATTERIES; CONDUCTION-BAND ELECTRONS; VISIBLE-LIGHT
   IRRADIATION; ENHANCED PHOTOELECTROCATALYTIC DEGRADATION; MODULATED
   PHOTOCURRENT SPECTROSCOPY
ER

PT J
DE cyclic voltammetry; electron traps; nanostructures;
   photoelectrochemistry; titanium dioxide
ID SENSITIZED SOLAR-CELLS; TITANIUM-DIOXIDE; THIN-FILMS; NANOCRYSTALLINE
   TIO2; AQUEOUS-ELECTROLYTE; SURFACE-STATES; SIZE; ANATASE; TRANSPORT;
   GROWTH
ER

PT J
ID MULTIPLE-SCLEROSIS; CLINICAL-FEATURES; CHILDREN; AUTOANTIBODIES;
   DEMYELINATION; ANTIGEN; CELLS
ER

PT J
DE Space radiation; Dosimetry; Passive radiation detectors;
   Thermoluminescence; EXPOSE-E
ID INTERNATIONAL-SPACE-STATION; DOSIMETRY; ISS; DETECTORS; ONBOARD; TRACK
ER

PT J
DE Interferon-beta; multiple sclerosis; neutralizing antibodies;
   persistency; titer
ID MULTIPLE-SCLEROSIS PATIENTS; 3-YEAR FOLLOW-UP; RELAPSING MS; IFN-BETA;
   EFFICACY; THERAPY; IMPACT; IMMUNOGENICITY; NAB
ER

PT J
DE Children; False memory; Compliance; Memory
ID AUTOBIOGRAPHICAL MEMORY; SUGGESTIBILITY; TRUE; EVENT; MISINFORMATION;
   INFORMATION; BELIEFS; PLAUSIBILITY; VALIDITY; CRITERIA
ER

PT J
ID NECROSIS-FACTOR-ALPHA; RHEUMATOID-ARTHRITIS; MICE; INFECTION; FAMILY;
   CELLS; METALLOPROTEINASE; MONOCYTOGENES; DISINTEGRIN; MATURATION
ER

PT J
DE Neuromyelitis optica; autoantibodies; myelin oligodendrocyte
   glycoprotein; aquaporin-4; complement mediated cytotoxicity; biomarker
ID ACUTE DISSEMINATED ENCEPHALOMYELITIS; EXTENSIVE TRANSVERSE MYELITIS;
   PEDIATRIC MULTIPLE-SCLEROSIS; ANTI-AQUAPORIN-4 ANTIBODY; DEMYELINATING
   DISEASES; DIAGNOSTIC-CRITERIA; BASIC-PROTEIN; WATER CHANNEL; IGG
   PREDICTS; T-CELL
ER

PT J
ID PLACEBO-CONTROLLED TRIAL; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY;
   AGOUTI RAT MODEL; DOUBLE-BLIND; RHEUMATIC-DISEASES; INTERFERON BETA-1B;
   LEFLUNOMIDE; ENCEPHALOMYELITIS; SEGMENTATION; MULTICENTER
ER

PT J
ID HEART-FAILURE
ER

PT J
DE barrel cortex; CAN channels; M1; patch-clamp; TRPC channels; V1
ID SOMATOSENSORY CORTEX; ENTORHINAL CORTEX; WORKING-MEMORY; PREFRONTAL
   CORTEX; BASAL FOREBRAIN; CEREBRAL-CORTEX; III NEURONS; IN-VIVO;
   CHANNELS; SYSTEM
ER

PT J
DE Impact assessment; Integrated modeling; Land use cover change;
   Mathematical programming; Multi-; agent systems; Technology adoption
ID WATER-RESOURCES ASSESSMENT; LAND-USE CHANGE; NORTHERN THAILAND; HIGHLAND
   CATCHMENTS; HYDROLOGICAL-MODEL; MULTIAGENT SYSTEMS; BIOECONOMIC MODEL;
   MANAGEMENT; DYNAMICS; FARM
ER

PT J
ID PHASE-II EXTENSION; ORAL FINGOLIMOD; FTY720
ER

PT J
DE Neuromyelitis optica; Aquaporin-4; Cerebrospinal fluid; Clinical
   activity; Longitudinal study
ID NMO-IGG; AQUAPORIN-4; IMMUNOGLOBULIN; MARKER
ER

PT J
ID CORONAL MASS EJECTIONS; QUIESCENT PROMINENCE; HELICAL FLUX; HINODE;
   EMERGENCE; CONFINEMENT; INSTABILITY; TELESCOPE; DYNAMICS; MISSION
ER

PT J
DE Internet treatment; Social anxiety disorder; Guided self-help;
   Randomized controlled trial (RCT)
ID COGNITIVE-BEHAVIOR THERAPY; PANIC DISORDER; PSYCHOLOGICAL TREATMENTS;
   POSTTRAUMATIC STRESS; APPLIED RELAXATION; ANXIETY DISORDERS; FOLLOW-UP;
   DEPRESSION; PSYCHOTHERAPY; METAANALYSIS
ER

PT J
DE Acute disseminated encephalomyelitis; Clinically isolated syndrome;
   Multiple sclerosis; Myelin oligodendrocyte glycoprotein; Cerebrospinal
   fluid; Autoantibodies
ID MYELIN OLIGODENDROCYTE GLYCOPROTEIN; ACUTE DISSEMINATED
   ENCEPHALOMYELITIS; PEDIATRIC MULTIPLE-SCLEROSIS; BASIC-PROTEIN;
   FOLLOW-UP; B-CELLS; DISORDERS; AUTOANTIBODIES; FREQUENCY; CHILDREN
ER

PT J
DE Charge-trapping Flash (CTF); HfON; ion implant; nonvolatile memory (NVM)
ID SPEED
ER

PT J
DE Acetylcholine; Association; Behavioral state; Nucleus basalis
ID RECEPTIVE-FIELD PLASTICITY; BASAL FOREBRAIN NEURONS; PRIMARY
   AUDITORY-CORTEX; NUCLEUS BASALIS; CEREBRAL-CORTEX;
   CONDITIONED-RESPONSES; PHYSIOLOGICAL MEMORY; ASSOCIATIVE MEMORY;
   GUINEA-PIG; STIMULATION
ER

PT J
ID BUNDLE-BRANCH BLOCK; CARDIAC-RESYNCHRONIZATION THERAPY; HEART-FAILURE;
   MODEL; ELECTROPHYSIOLOGY; ATRIAL
ER

PT B
DE Feature models; feature similarity; variability modeling
ER

PT J
ID GELATINASE-ASSOCIATED LIPOCALIN; ISCHEMIA-REPERFUSION INJURY; NEPHRON
   REDUCTION; RENAL LESIONS; IRON; GROWTH; PATHOGENESIS; EXPRESSION;
   RECEPTOR; PROTEIN
ER

PT J
ID PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; SOLUBLE ADHESION MOLECULES;
   RELAPSING MULTIPLE-SCLEROSIS; ALPHA-CONVERTING ENZYME; INTERFERON-BETA;
   CELL-ADHESION; MONOCLONAL-ANTIBODIES; CONTROLLED TRIAL; VCAM-1; BLOOD
ER

PT J
ER

PT J
ER

PT J
ID MULTIPLE-SCLEROSIS; DIAGNOSTIC-CRITERIA; PATHOGENESIS; IGG; DISTINCTION;
   PREDICTORS; RITUXIMAB; MARKER; NMO
ER

PT J
ID NECROSIS-FACTOR-ALPHA; GELATINASE-ASSOCIATED LIPOCALIN; ADIPOSE-TISSUE;
   NEUTROPHIL GELATINASE; TNF-ALPHA; MICE; INFLAMMATION; ADIPOCYTES;
   EXPRESSION; IDENTIFICATION
ER

PT J
ID EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; PHASE-II EXTENSION; RECEPTOR
   AGONISTS; LYMPHOCYTE EGRESS; FTY720; BETA-1A; ORGANS; MS
ER

PT J
DE amyloid beta; apolipoprotein; dementia; lipid; oxysterols; statins
ID BLOOD-BRAIN-BARRIER; AMYLOID PRECURSOR PROTEIN; LOW-DENSITY-LIPOPROTEIN;
   APOLIPOPROTEIN-A-II; CENTRAL-NERVOUS-SYSTEM; RECEPTOR-RELATED PROTEIN;
   TRANSGENIC MOUSE MODEL; ESTER TRANSFER PROTEIN; POLYUNSATURATED
   FATTY-ACIDS; E MESSENGER-RNA
ER

PT J
ID MYELIN OLIGODENDROCYTE GLYCOPROTEIN; EXPERIMENTAL AUTOIMMUNE
   ENCEPHALOMYELITIS; EATON MYASTHENIC SYNDROME; MULTIPLE-SCLEROSIS;
   PASSIVE TRANSFER; ANTI-AQUAPORIN-4 ANTIBODY; ALLERGIC ENCEPHALOMYELITIS;
   AQUAPORIN-4 ANTIBODIES; NERVOUS-SYSTEM; WATER CHANNEL
ER

PT J
ID FOLLOW-UP; NEUTRALIZING ANTIBODIES; DIAGNOSTIC-CRITERIA; DEMYELINATING
   EVENT; DISABILITY; MRI; MS; IMPAIRMENT; DEFINITE; GUIDELINES
ER

PT J
ER

PT J
DE Internet-based treatment; social phobia; randomized controlled trial;
   cognitive-behavioral therapy; computer
ID SELF-HELP; COGNITIVE THERAPY; PSYCHOTHERAPY-RESEARCH; ANXIETY DISORDER;
   PUBLIC SPEAKING; PANIC DISORDER; GROUP EXPOSURE; MENTAL-HEALTH;
   AGORAPHOBIA; SUPPORT
ER

PT J
ID PLACEBO-CONTROLLED TRIAL; DOUBLE-BLIND; FOLLOW-UP; BRAIN ATROPHY;
   DISABILITY; LESIONS; MRI; MS; PROGRESSION; PARALLEL
ER

PT J
DE Al2O3; AlO- ion implantation; deep trap; nonvolatile-memory (NVM)
ER

PT J
ID UROPATHOGENIC ESCHERICHIA-COLI; MUCOSAL HOST-DEFENSE; SEROVAR
   TYPHIMURIUM; INNATE IMMUNITY; VIRULENCE FACTORS; IRON-METABOLISM;
   GENE-CLUSTER; T-CELLS; INFECTION; MICE
ER

PT J
ID GELATINASE-ASSOCIATED LIPOCALIN; HUMAN NEUTROPHIL GELATINASE;
   COLONY-STIMULATING FACTOR; CHRONIC MYELOID-LEUKEMIA; BLOOD-STREAM
   INFECTIONS; ACUTE-PHASE PROTEIN; NF-KAPPA-B; PNEUMONIAE INFECTION;
   ESCHERICHIA-COLI; EXPRESSION
ER

PT J
ID ENTHESITIS-RELATED ARTHRITIS; RHEUMATOID-ARTHRITIS; PRELIMINARY
   DEFINITION; IMPROVEMENT; CHILDREN; TRIAL; PROGNOSIS; UVEITIS
ER

PT J
ID COGNITIVE-BEHAVIORAL TREATMENT; PROBLEM-SOLVING TREATMENT;
   MENTAL-HEALTH-CARE; MAJOR DEPRESSION; ANTIDEPRESSANT MEDICATION;
   CLINICAL-SIGNIFICANCE; RESPONSIVE REGULATION; TREATMENT DURATION;
   ROUTINE PRACTICE; PSYCHOTHERAPY
ER

PT J
ID RANDOMIZED CONTROLLED-TRIAL; COGNITIVE-BEHAVIOR THERAPY; SOCIAL PHOBIA;
   PANIC DISORDER; SELF-HELP; POSTTRAUMATIC-STRESS; DEPRESSION; ONLINE;
   ALLIANCE; DISTRESS
ER

PT J
ID LOW-EARTH-ORBIT; COSMIC-RAYS; DOSIMETRY; DETECTORS; CODE
ER

PT J
DE Ion implanted polymers; Organic field-effect devices;
   Polymethylmethacrylate (PMMA)
ID POLYMERIC GATE ELECTRET; EFFECT TRANSISTORS; POLYMETHYLMETHACRYLATE;
   ELEMENT; CHARGE
ER

PT J
ID MULTIPLE-SCLEROSIS; WATER CHANNEL; IGG; PATHOGENESIS; DISTINCTION;
   MECHANISMS; RITUXIMAB; DISEASE; MARKER; NMO
ER

PT J
DE Sun: prominences; Sun: UV radiation; techniques: spectroscopic
ID X-RAY TELESCOPE; TRANSITION REGION; CORONAL EXPLORER; ABSORPTION
   FEATURES; EUV-FILAMENT; MODEL PROMINENCES; EMITTED RADIATION; SOLAR
   PROMINENCES; NEUTRAL HYDROGEN; ATOMIC DATABASE
ER

PT J
DE Multiple Sclerosis; immunotherapy; randomized trials; monoclonal
   antibodies; interferon beta; glatirameracetate; treatment escalation
ID PLACEBO-CONTROLLED TRIAL; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS;
   CLINICALLY ISOLATED SYNDROMES; 1ST DEMYELINATING EVENT; INTRAVENOUS
   IMMUNOGLOBULIN TREATMENT; MITOXANTRONE-INDUCED CARDIOTOXICITY;
   GLATIRAMER ACETATE COPAXONE(R); INTERFERON-BETA THERAPY; NEUTRALIZING
   ANTIBODIES; DOUBLE-BLIND
ER

PT J
ID MEMBRANE-PROTEIN; APICAL MEMBRANE; PLASMA-MEMBRANE; MYOSIN-VB; ATROPHY;
   RAB8
ER

PT J
DE clinically isolated syndrome; disease progression; multiple sclerosis;
   smoking
ID 1ST DEMYELINATING EVENT; CIGARETTE-SMOKING; DIAGNOSTIC-CRITERIA;
   ORAL-CONTRACEPTIVES; PROGRESSION; GUIDELINES; CYANIDE; TOBACCO; DISEASE;
   MRI
ER

PT J
ER

PT J
ID ELECTRON-BEAM IRRADIATION; ACCELERATED HEAVY-IONS; DOUBLE-STRAND BREAKS;
   LONG-TERM SURVIVAL; UV-RADIATION; BACTERIAL-SPORES;
   DEINOCOCCUS-RADIODURANS; PHOTOPRODUCT LYASE; POLYCHROMATIC UV;
   ENDOSPORES
ER

PT J
DE Sun : granulation; Sun : magnetic fields; techniques : polarimetric
ID STOKES PROFILE ANALYSIS; SOLAR PHOTOSPHERE; FIELDS; RESOLUTION;
   POLARIZATION; SIMULATIONS; EMERGENCE; INVERSION; NETWORK; LINES
ER

PT J
ID RESISTANCE; OXIDE
ER

PT J
DE charge trapping; EPR spectroscopy; luminescence; nanostructures;
   photochemistry
ID ELECTRON-PARAMAGNETIC-RESONANCE; SOLAR-ENERGY CONVERSION; PHOTOCATALYTIC
   ACTIVITY; TIO2 NANOCRYSTALS; SEMICONDUCTOR NANOCRYSTALS; STRUCTURAL
   FEATURES; TITANIUM-DIOXIDE; SURFACE SCIENCE; OXIDE SURFACES; NANOTUBES
ER

PT J
DE dendritic cells; toll-like receptors; interleukins
ID TOLL-LIKE RECEPTORS; PHOSPHODIESTER CPG OLIGONUCLEOTIDES; SIGNALING
   PATHWAYS; BACTERIAL-DNA; MICROBIAL RECOGNITION; INNATE IMMUNITY;
   DOWN-REGULATION; CUTTING EDGE; BONE-MARROW; CLASS-II
ER

PT J
DE agent-based modeling; agriculture; integrated modeling; MP-MAS;
   technology diffusion; tropical soil productivity calculator
ID AGENT-BASED SIMULATION; LAND-USE CHANGE; NUTRIENT BALANCES; EASTERN
   UGANDA; MARKET DEVELOPMENT; DECISION-MAKING; FARMING SYSTEMS;
   MANAGEMENT; MODELS; HIGHLANDS
ER

PT J
ID H-ALPHA; FILAMENTS; DYNAMICS; THREADS; LIMB; MASS; MOTIONS; REGION
ER

PT J
DE multiple sclerosis; pathophysiology; biomarkers; antibodies;
   differential therapy
ID MYELIN OLIGODENDROCYTE GLYCOPROTEIN; INTRATHECAL IGM SYNTHESIS;
   ANTIMYELIN BASIC-PROTEIN; RELAPSING-REMITTING MULTIPLE;
   CEREBROSPINAL-FLUID; NEUROMYELITIS-OPTICA; DEMYELINATING EVENT;
   PROTEOLIPID PROTEIN; ANTIBODY-RESPONSES; AXON REGENERATION
ER

PT J
ID SENSITIZED SOLAR-CELLS; ELECTRON-TRANSPORT; TITANIUM-DIOXIDE;
   AQUEOUS-ELECTROLYTE; TIO2 ELECTRODES; SURFACE; NANOPARTICLES; ZNO;
   ACCUMULATION; SPECTROSCOPY
ER

PT J
ID SOMATOSENSORY CORTEX; SPATIOTEMPORAL DYNAMICS; ELECTRICAL-ACTIVITY;
   SENSORY RESPONSES; CORTICAL DYNAMICS; PYRAMIDAL NEURONS; SENSITIVE DYES;
   NEOCORTICAL NETWORKS; OPTICAL RECORDINGS; RECEPTIVE-FIELDS
ER

PT J
DE apoptosis; granulocytes; heart transplantation; ischemia and
   reperfusion; Lcn-2 knock out; lipocalin-2
ID GELATINASE-ASSOCIATED LIPOCALIN; ACUTE-PHASE PROTEIN; ACUTE RENAL
   INJURY; EPITHELIAL-CELLS; TRANSCRIPTION FACTORS; NEUTROPHIL; APOPTOSIS;
   EXPRESSION; NGAL; IRON
ER

PT J
ID PHOTOPRODUCT LYASE GENE; ACID-SOLUBLE PROTEINS; BACTERIAL-SPORES; STRAND
   BREAKS; HUMAN SPACEFLIGHT; THYMINE DIMERS; HEAVY-IONS; GERMINATION;
   SPORULATION; ENDOSPORES
ER

PT J
DE clinically isolated syndrome; prognosis; multiple sclerosis; antimyelin
   antibodies
ID MYELIN-OLIGODENDROCYTE GLYCOPROTEIN; CENTRAL-NERVOUS-SYSTEM;
   MULTIPLE-SCLEROSIS PATHOLOGY; 1ST DEMYELINATING EVENT;
   CEREBROSPINAL-FLUID; BASIC-PROTEIN; FOLLOW-UP; NEUROLOGICAL DISEASES;
   MONOCLONAL-ANTIBODY; PREDICTIVE VALUE
ER

PT J
ID ANATASE TIO2; STRUCTURAL FEATURES; SURFACE-CHEMISTRY; NANOTUBE ARRAYS;
   SOLAR-CELLS; LUMINESCENCE; NANOCRYSTALS; PHOTOLUMINESCENCE; ABSORPTION;
   SHAPE
ER

PT J
ID ANTI-MOG
ER

PT J
DE cochlear implant, children; mismatch negativity; working memory;
   auditory sensory memory
ID EVENT-RELATED POTENTIALS; PROFOUNDLY DEAF-CHILDREN; MISMATCH NEGATIVITY
   MMN; SPEECH-PERCEPTION; LANGUAGE-ACQUISITION; IMPAIRED CHILDREN;
   MATURATION; STIMULI; DISCRIMINATION; REPRESENTATION
ER

PT J
ER

PT J
DE holistic medicine and health; clinical holistic medicine; CAM;
   psychodynamic therapy; symbolic incest; energetic incest; implanted
   memories; implanted philosophy; holistic sexology; bodywork; vaginal
   acupressure
ID QUALITY-OF-LIFE; MENTAL-DISORDERS; CHRONIC PAIN; BODYWORK; MINDFUL;
   DISEASES; ABILITY; ILLNESS; HEALTH
ER

PT J
DE common sampling frame; generation of statistically consistent agent
   populations; integrated modeling; interdisciplinary data collection;
   Monte Carlo approach; Uganda
ID BIOECONOMIC MODEL; LAND DEGRADATION; SIMULATION; MANAGEMENT; UGANDA
ER

PT J
ID ATRIAL
ER

PT J
DE titanium dioxide; nanoporous electrode; charge transfer reductive
   doping; photoelectrochemical water oxidation; electron accumulation
ID SEMICONDUCTOR ELECTRODES; AQUEOUS-SOLUTION; SURFACE-STATES; HYDROGEN;
   ANATASE; ACCUMULATION
ER

PT J
DE multiple sclerosis; heterogeneity; biological markers; antibodies;
   differential therapeutic concept
ID MYELIN-OLIGODENDROCYTE GLYCOPROTEIN; EPSTEIN-BARR-VIRUS; PROGRESSIVE
   MULTIPLE-SCLEROSIS; INTRATHECAL IGM SYNTHESIS; ANTIMYELIN BASIC-PROTEIN;
   B-CELL RESPONSES; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS;
   RELAPSING-REMITTING MULTIPLE; CEREBROSPINAL-FLUID; NEUROMYELITIS-OPTICA
ER

PT J
DE Nabilone; synthetic cannabinoid; spasticity; central pain
ID MULTIPLE-SCLEROSIS; MANAGEMENT; RECEPTORS; MARIJUANA; EFFICACY; BRAIN;
   SAFE
ER

PT J
ID PHANTOM
ER

PT J
DE ASSR; auditory steady-state response; cochlear delay time; hearing
   threshold assessment; objective audiometry
ID BRAIN-STEM RESPONSES; HEARING THRESHOLDS; EVOKED-POTENTIALS; MODULATED
   TONES; CHILDREN; HUMANS
ER

PT J
DE autoantibody; myelin oligodendrocyte glycoprotein; epitopes;
   interferon-beta; glatiramer-acetate; relapse
ID EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; MULTIPLE-SCLEROSIS PATIENTS;
   B-CELL RESPONSES; PLACEBO-CONTROLLED TRIAL; MOG-DEFICIENT MICE; T-CELL;
   MYELIN/OLIGODENDROCYTE GLYCOPROTEIN; ANTIMYELIN ANTIBODIES;
   DOUBLE-BLIND; ANTI-MOG
ER

PT J
ID OXIDE SURFACES; OXYGEN VACANCY; PHOTOCATALYSIS; TRANSFORMATION;
   NANOPARTICLES; ADSORPTION; CHEMISTRY; RESONANCE; TITANIA; SYSTEMS
ER

PT J
DE diversity of constraints to agricultural development; empirical
   multi-agent systems; bio-economic modeling; ex ante assessment of policy
   options
ID BIOECONOMIC MODEL; LAND DEGRADATION; AGRICULTURE; AFRICA
ER

PT J
DE advanced melanoma; dentric cells; DTIC; first-line therapy; melanoma
ID CLINICAL-APPLICATION; MALIGNANT-MELANOMA; SOLID TUMORS; MATURE;
   GENERATION; IMMUNOTHERAPY; GUIDELINES; INDUCTION; EVALUATE
ER

PT J
DE shape memory alloys; TiNi; surface properties
ID TRIBOLOGICAL PROPERTIES; NI ALLOY; IMMERSION; TITANIUM; WEAR; BEHAVIOR
ER

PT J
ID PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; PLACEBO-CONTROLLED TRIAL;
   DOUBLE-BLIND; RHEUMATOID-ARTHRITIS; T-CELLS; DISABILITY; THERAPY;
   METHOTREXATE; MULTICENTER; COMBINATION
ER

PT J
DE 24p3; bacteriostatic; kidney ischemia-reperfusion injury; NGAL
ID GELATINASE-ASSOCIATED LIPOCALIN; ACUTE RENAL INJURY; INVASIVE STRAINS;
   PROTEIN FAMILY; IRON; APOPTOSIS; MOUSE; GENE; IDENTIFICATION;
   SPERMATOZOA
ER

PT J
DE sperm; sperm capacitation; lipid rafts; detergent resistant membranes;
   sulfogalactosylglycerolipid; cholesterol; zona pellucida
ID T-CELL-RECEPTOR; GLYCOSYLPHOSPHATIDYLINOSITOL-ANCHORED PROTEINS;
   DETERGENT-INSOLUBLE MEMBRANE; MOUSE SPERM; TYROSINE PHOSPHORYLATION;
   SIGNAL-TRANSDUCTION; PLASMA-MEMBRANE; ACROSOME REACTION; PORCINE SPERM;
   SPECTROSCOPIC EVIDENCE
ER

PT J
ID ELECTRON-PARAMAGNETIC-RESONANCE; RESOLVED MICROWAVE CONDUCTIVITY;
   CHARGE-CARRIER DYNAMICS; ABSORPTION-SPECTROSCOPY; TITANIUM DIOXIDE;
   TRAPPED HOLES; SOLAR-CELLS; SURFACE; PARTICLES; ANATASE
ER

PT J
DE charge transfer; EPR spectroscopy; oxygen; TiO2 nanocrystals; UV-induced
   charge separation
ID GAS-PHASE PHOTOOXIDATION; REDUCED TITANIUM-DIOXIDE; NANOSTRUCTURED TIO2;
   HETEROGENEOUS PHOTOCATALYSIS; SPIN-RESONANCE; OXIDE SURFACES; RUTILE
   SURFACES; HYDROXYL-GROUPS; COLLOIDAL TIO2; UV IRRADIATION
ER

PT J
DE multiple sclerosis; soluble platelet endothelial cell adhesion
   molecule-1 (sPECAM-1); soluble e-selectin (sE-selectin); soluble
   p-selectin (sP-selectin); plasma
ID BLOOD-BRAIN-BARRIER; PRIMARY PROGRESSIVE DISEASE;
   CENTRAL-NERVOUS-SYSTEM; TRANSENDOTHELIAL MIGRATION; CEREBROSPINAL-FLUID;
   P-SELECTIN; PECAM-1; SERUM; EXPRESSION; LEUKOCYTES
ER

PT J
ID ELECTRON TRAPS; AB-INITIO; DEFECT CENTERS; COLOR-CENTERS; EARTH OXIDES;
   DENSITY; ANIONS; NANOPARTICLES; VACANCIES; SITES
ER

PT J
DE biventricular pacing; ventricular repolarization; congestive heart
   failure; body surface electrocardiography
ID INTRAVENTRICULAR-CONDUCTION DELAY; QT DISPERSION; BODY-SURFACE;
   GENERAL-POPULATION; JT INTERVAL; LONG QT; MORTALITY; CARDIOMYOPATHY;
   MARKER; RISK
ER

PT J
ID BAND ULTRAVIOLET-B; A RADIATION PUVA; FOLLOW-UP; MALIGNANT-MELANOMA;
   UNITED-STATES; COAL-TAR; PSORIASIS; PHOTOCARCINOGENESIS; CARCINOMA;
   TUMORS
ER

PT J
ID INFRARED-ABSORPTION SPECTROSCOPY; TITANIUM-DIOXIDE; HETEROGENEOUS
   PHOTOCATALYSIS; OXIDE SURFACES; VISIBLE-LIGHT; PARAMAGNETIC-RESONANCE;
   SPECTRAL DEPENDENCE; TRAPPED HOLES; ELECTRON; OXYGEN
ER

PT J
DE channel capacity; feedback; Markov channel; typicality
ID SIDE INFORMATION
ER

PT J
DE dendritic cells; cell culture; closed system; cell factories (TM);
   immunotherapy; vaccination; elutriation; counterflow centrifugation
ID METASTATIC MELANOMA; MATURE; IMMUNOTHERAPY; VACCINATION; FACTORIES(TM);
   ENRICHMENT; CULTURE
ER

PT J
DE BK channels; density; immunohistochemistry; neocortical pyramidal
   neurons
ID CA2+-ACTIVATED K+ CHANNELS; ACTION-POTENTIAL REPOLARIZATION;
   HIPPOCAMPAL-NEURONS; CURRENTS; CA2+; INITIATION; TRANSIENTS; SUBTYPES;
   SUBUNIT; DISTAL
ER

PT J
DE biodegradable shape-memory polymers; polymer systems; stimuli-sensitive
   implant materials; smart suture
ID OLIGO(EPSILON-CAPROLACTONE) SEGMENTS; BIOMEDICAL APPLICATIONS; IN-VITRO;
   ANGIOGENESIS; NETWORKS; STERILIZATION
ER

PT J
DE immunodeficiency; T lymphocytes; B lymphocytes; autoimmunity
ID STEM-CELL TRANSPLANTATION; DOSE IMMUNOSUPPRESSIVE THERAPY;
   HUMAN-IMMUNODEFICIENCY-VIRUS; BONE-MARROW-TRANSPLANTATION; MYELIN
   OLIGODENDROCYTE GLYCOPROTEIN; PERIPHERAL-BLOOD; MULTIPLE-SCLEROSIS;
   T-CELLS; LYMPHOPROLIFERATIVE DISEASE; CLINICAL-MANIFESTATIONS
ER

PT J
DE multiple sclerosis; immunotherapy; consensus
ID CLINICALLY ISOLATED SYNDROMES; RELAPSING-REMITTING MS; INTERFERON
   BETA-1A; CONTROLLED-TRIAL; DOUBLE-BLIND; DIAGNOSTIC-CRITERIA; GLATIRAMER
   ACETATE; RANDOMIZED-TRIAL; OPTIC NEURITIS; INTRAVENOUS IMMUNOGLOBULIN
ER

PT J
DE CEO problem; contra-polymatroid; decentralized estimation; Gaussian
   source; multiterminal source coding; mean-squared error; rate
   allocation; water-filling
ID SIDE INFORMATION; DECODER; CHANNELS
ER

PT J
DE bioactive NiTi alloy; hydroxyapatite layer; implants; bone bonding;
   interface
ID COATED TITANIUM; APATITE LAYER; RESPONSES; SURFACE
ER

PT J
DE ILT; dendritic cells; plasmacytoid dendritic cells; CpG-DNA;
   inflammatory stimuli
ID BACTERIAL CPG-DNA; IG-LIKE RECEPTORS; INHIBITORY RECEPTORS; MODULATE
   FUNCTION; LYMPHOID-CELLS; MYELOID CELLS; ANTIGEN; INTERFERON; FAMILY;
   SUPERFAMILY
ER

PT J
DE technology; computer; psychotherapy; training; supervision
ID LATENT SEMANTIC ANALYSIS; ASSISTED-INSTRUCTION; SUPERVISION;
   ACQUISITION; PSYCHOLOGY; EAR
ER

PT J
DE atherosclerosis; inflammation; immunology; dendritic cells; statins
ID ENDOTHELIAL-CELLS; ADAPTIVE IMMUNITY; RHO-GTPASE; INFLAMMATION; STATINS;
   MATURE; INVOLVEMENT; PRAVASTATIN; EXPRESSION; GENERATION
ER

PT J
DE antibody; cerebrospinal fluid; multiple sclerosis; myelin; neurological
   diseases; Nogo-A
ID SPINAL-CORD-INJURY; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; INHIBITS
   NEURITE OUTGROWTH; CORTICOSPINAL TRACT FIBERS; ADULT-RAT; MESSENGER-RNA;
   AXON REGENERATION; PROTECTIVE AUTOIMMUNITY; DEMYELINATING DISEASE;
   MONOCLONAL-ANTIBODY
ER

PT J
ID PROPAGATING ACTION-POTENTIALS; RAT SOMATOSENSORY CORTEX; DISTAL APICAL
   DENDRITES; CELL DENDRITES; CATION CURRENT; BARREL CORTEX; ION CHANNELS;
   VIVO; PACEMAKER; MOUSE
ER

PT J
DE active MS lesions; contrast-enhanced MRI; MR spectroscopic imaging;
   lactate
ID PROTON MR SPECTROSCOPY; BRAIN METABOLITE CHANGES; APPEARING
   WHITE-MATTER; GADOLINIUM-DTPA; INTRAVENOUS METHYLPREDNISOLONE; BARRIER
   BREAKDOWN; AXONAL DAMAGE; PLAQUES; DEMYELINATION; DISABILITY
ER

PT J
DE CD59; cytotoxic T-cell response; c9neo antigen; granzyme B;
   Guillain-Barre syndrome
ID EXPERIMENTAL ALLERGIC NEURITIS; IDIOPATHIC DEMYELINATING
   POLYRADICULONEUROPATHY; PERIPHERAL NERVOUS-SYSTEM; RAT SCHWANN-CELLS;
   TERMINAL COMPLEMENT; MULTIPLE-SCLEROSIS; IN-VITRO;
   MONOCLONAL-ANTIBODIES; DEPENDENT CYTOLYSIS; PLASMA-EXCHANGE
ER

PT J
ID MYELIN OLIGODENDROCYTE GLYCOPROTEIN; EXPERIMENTAL AUTOIMMUNE
   ENCEPHALOMYELITIS; BASIC-PROTEIN; FOLLOW-UP; DISEASE; CRITERIA; RAT;
   MRI; CNS; DIAGNOSIS
ER

PT J
DE activation time imaging; noninvasive electrocardiography; inverse
   problem; atrium; validation; focal arrhythmias; paced rhythm data
ID BIDOMAIN MODEL; CARDIAC TISSUE; TIME; FIBRILLATION; ARRHYTHMIAS;
   LOCALIZATION; ALGORITHM; ABLATION; BOUNDARY; CATHETER
ER

PT J
DE multiple sclerosis; demyelination; hypoxia; cerebrospinal fluid; canine
   distemper
ID CANINE-DISTEMPER VIRUS; MYELIN-ASSOCIATED GLYCOPROTEIN; NITRIC-OXIDE;
   BASIC-PROTEIN; DEMYELINATION; ANTIBODIES; PATHOGENESIS;
   OLIGODENDROCYTES; HETEROGENEITY; COMPLEMENT
ER

PT J
DE TiNi shape memory alloy; N+ ion implantation; TiN
ER

PT J
ID TEMPORAL CORRELATION HYPOTHESIS; VISUAL FEATURE INTEGRATION; NEURONS
   IN-VITRO; BARREL CORTEX; SYNAPTIC ORGANIZATION; ACTION-POTENTIALS;
   NEOCORTEX; DENDRITES; INPUTS; TIME
ER

PT J
ID MAGNESIUM-OXIDE; REACTIVITY; VACANCIES
ER

PT J
DE dendritic cells; closed system; cell factories (TM); immunotherapy;
   vaccination
ID STAGE-IV MELANOMA; CYTOTOXIC T-CELLS; HUMAN BLOOD; VACCINATION;
   IMMUNOTHERAPY; RESPONSES; INJECTION; INDUCTION
ER

PT J
DE activation time map; atrium; electrocardiographic (ECG) mapping; human
   heart; inverse problem; magnetic resonance imaging; modeling; ventricle
ID BODY-SURFACE; BIDOMAIN MODEL; EPICARDIAL POTENTIALS; ATRIAL ARRHYTHMIAS;
   BIOELECTRIC EVENTS; INVERSE PROBLEM; HUMAN-HEART; ACTIVATION;
   RECONSTRUCTION; LOCALIZATION
ER

PT J
DE dendritic cells; vaccination; CD4(+) T cells; T helper cells; tumor
   immunity
ID IMMUNE-RESPONSES; ANTITUMOR IMMUNITY; CANCER-PATIENTS; ANTIGENS;
   IMMUNOTHERAPY; LYMPHOMA; IMMUNIZATION; LYMPHOCYTES; GENERATION;
   INJECTION
ER

PT J
ID SEXUAL ABUSE; TEENAGE PREGNANCY; RISK; CHILDHOOD; VICTIMIZATION; GIRLS
ER

PT J
DE paraoxonase; transgenic mice; lipid peroxidation; lecithin : cholesterol
   acyltransferase; highdensity lipoproteins
ID CHOLESTEROL ACYLTRANSFERASE ACTIVITY; INHIBIT PLASMA LECITHIN; SERUM
   PARAOXONASE; LIPID HYDROPEROXIDES; OXIDIZED LDL; 3 STEPS;
   APOLIPOPROTEIN; PHOSPHOLIPIDS; ARYLESTERASE; PROTECTION
ER

PT J
ID QUANTUM
ER

PT J
DE nanocrystal; ion implantation; non-volatile memory
ID RETENTION; CHARGE
ER

PT J
DE apolipoprotein D (apoD); multiple sclerosis (MS); neurological diseases;
   lipid metabolism; disease progression
ID NEUROLOGICAL DISORDERS; INCREASED EXPRESSION; TISSUE DISTRIBUTION;
   PERIPHERAL-NERVE; RAT HIPPOCAMPUS; MESSENGER-RNA; IGG ANALYSES;
   IDENTIFICATION; PRINCIPLES; ALBUMIN
ER

PT J
ID APOE EPSILON-4 ALLELE; CHOLESTEROL TRANSPORT; ALZHEIMERS-DISEASE; E
   POLYMORPHISM; DISABILITY; INJURY; BRAIN; SUSCEPTIBILITY; REGENERATION;
   EXPRESSION
ER

PT J
DE diffusion of innovations; inter-household linkages; policy analysis;
   multi-agent systems; cellular automata
ER

PT J
ID HUMAN B-LYMPHOCYTES; CD4(+) T-CELLS; MEASLES-VIRUS; CELLULAR RECEPTOR;
   ENCODING GENE; SLAM; MATURATION; PROLIFERATION; ENGAGEMENT; RESPONSES
ER

PT J
ID DATA-STORAGE; UP-CONVERSION; LUMINESCENCE; PROPOSAL; FILMS; LASER;
   LIMIT; BLUE
ER

PT J
DE CD4(+)CD25(+) T cells; regulatory T cells; immune tolerance; anergy;
   dendritic cells
ID IMMUNOLOGICAL SELF-TOLERANCE; LYMPHOCYTE-ASSOCIATED ANTIGEN-4; DENDRITIC
   CELLS; INDUCTION; AUTOIMMUNITY; CD25; GENERATION; RESPONSES; IMMUNITY;
   CTLA-4
ER

PT J
ID MULTIPLE-SCLEROSIS; IGG SUBCLASSES; INTERFERON BETA-1B;
   DIABETIC-PATIENTS; INSULIN; VACCINE; RESPONSES; IMMUNIZATION; THERAPY
ER

PT J
DE multiple sclerosis; autoimmunity; myelin oligodendrocyte glycoprotein
   (MOG); B cell response; autoantibody; epitope specificity
ID EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; EXPERIMENTAL AUTOIMMUNE
   ENCEPHALOMYELITIS; B-CELL; BASIC-PROTEIN; T-CELL; DEMYELINATION;
   ANTIBODY; LESIONS; RATS; MOG
ER

PT J
ID CORD SLICE CULTURES; ACTION-POTENTIALS; PACEMAKER CHANNELS; CATION
   CHANNELS; NEURONS; BRAIN; AMPLIFICATION; CONDUCTANCE; CURRENTS;
   INTEGRATION
ER

PT J
DE flow cytometry; spermatozoa; viability; mitochondria; rat; fluorescent
   probes
ID CRYOPRESERVED BOVINE SPERMATOZOA; FLUOROMETRIC ASSESSMENTS; INVITRO
   FERTILIZATION; ACROSOMAL INTEGRITY; DETECT REDUCTIONS; PROPIDIUM IODIDE;
   CELL VIABILITY; FERTILITY; JC-1; SYBR-14
ER

PT J
DE experimental autoimmune encephalitis; myelin oligodendrocyte
   glycoprotein autoantibody; multiple sclerosis
ID EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; CENTRAL-NERVOUS-SYSTEM;
   BASIC-PROTEIN; MULTIPLE-SCLEROSIS; DNA VACCINES; MYELIN/OLIGODENDROCYTE
   GLYCOPROTEIN; PROTEOLIPID PROTEIN; MEMBRANE TOPOLOGY; AUTOANTIBODIES;
   DISEASE
ER

PT J
ER

PT J
DE TNF-alpha; whole blood culture; PBMC culture; RT-PCR; anticoagulants
ID HUMAN WHOLE-BLOOD; POLYMERASE CHAIN-REACTION; TNF-ALPHA;
   MONONUCLEAR-CELLS; GENE-EXPRESSION; FLOW-CYTOMETRY; CYTOKINE; IL-1-BETA;
   STIMULATION; CULTURES
ER

PT J
ID PRE-MESSENGER-RNA; MEMBRANE SKELETAL PROTEIN-4.1;
   SPECTRIN-ACTIN-BINDING; ERYTHROCYTE PROTEIN-4.1; STRUCTURAL PROTEIN-4.1;
   4.1-BINDING SITE; TERNARY COMPLEX; GLYCOPHORIN-C; CELL-BODIES; DOMAIN
ER

PT J
DE multiple sclerosis; autoantibodies; myelin oligodendrocyte glycoprotein;
   myelin basic protein; brain inflammation
ID CENTRAL NERVOUS-SYSTEM; 2',3'-CYCLIC NUCLEOTIDE 3'-PHOSPHODIESTERASE;
   EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; CELLS SECRETING ANTIBODIES;
   CEREBROSPINAL-FLUID; PROTEOLIPID PROTEIN; MONOCLONAL-ANTIBODY;
   IMMUNOGLOBULIN-G; OPTIC NEURITIS; T-CELL
ER

PT J
ER

PT J
ID RECOMBINANT; PHARMACOKINETICS; PHARMACODYNAMICS; VOLUNTEERS
ER

EF